All News

Gene Therapy

Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
16 March 2023
Autologous vs Allogeneic: What Therapeutic Developers and Manufacturers Really Need to Know
Rupa Pike, Senior Director of
Coffee and a Cupcake: a Spotlight on Women in Advanced Therapies
8 March 2023
Coffee and a Cupcake: a Spotlight on Women in Advanced Therapies
Becky Johnson-Kent, Program Lead for
Manufacture of Healthy and Highly Functioning Gene-Edited Immune Cells
8 March 2023
Manufacture of Healthy and Highly Functioning Gene-Edited Immune Cells
Are you looking to engineer
Early Adoption and Partnerships – The Secret to Commercialization Success?
2 March 2023
Early Adoption and Partnerships – The Secret to Commercialization Success?
This Briefing from Advanced Therapies
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

UCL’s Targeted Gene Therapy Proves Promising Against Drug-Resistant Epilepsy
27 February 2023
UCL’s Targeted Gene Therapy Proves Promising Against Drug-Resistant Epilepsy
In this interview Professor Dimitri
First Gene Therapy for Hemophilia B Approved by the European Commission
24 February 2023
First Gene Therapy for Hemophilia B Approved by the European Commission
UniQure and its global biotechnology
FDA RMAT Designation Granted to Rocket Pharma’s Gene Therapy for Genetic Cardiac Disease
8 February 2023
FDA RMAT Designation Granted to Rocket Pharma’s Gene Therapy for Genetic Cardiac Disease
Leading late-stage biotechnology company Rocket
Increasing Advanced Therapies’ Connectivity and Speed to Market Through Partnership
3 February 2023
Increasing Advanced Therapies’ Connectivity and Speed to Market Through Partnership
Jeff Buck, Vice President, Adherence
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?